• March 19, 2015
    LONDON, UK - March 19, 2015 - Leading animal health company Zoetis Inc. unveiled its Centre for Digital Innovation (CDI) at the House of Lords today. Opened in the heart of London’s Tech City, the new Centre will create sophisticated digital products that enable data-driven decision-making to enhance precision farming and improve animal wellbeing for livestock and pets.Hosted by Lord Trees, the event was introduced by Lord de Mauley and attended by industry representatives including themore...
  • February 10, 2015
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) today announced that it has completed the purchase of the animal health assets of Abbott for a purchase price of $255 million, having fulfilled all closing requirements. The purchase expands Zoetis’ companion animal product portfolio to bring veterinarians solutions for anesthesia and treating pain and serious illnesses such as diabetes. It also brings novel cancer and pain compounds to the Zoetis pipelinemore...
  • January 13, 2015
    New York, NY – January 13, 2015 — Therapy dogs may improve the emotional well-being of some cancer patients, according to results of a clinical study, the first to document the benefits of animal-assisted therapy in adult cancer patients. The research was made available this week in the Journal of Community and Supportive Oncology.The study, conducted by researchers at Mount Sinai Beth Israel, found that patients receiving intensive multi-modal concomitant radiation therapy and chemotherapymore...
  • December 1, 2014
    FLORHAM PARK, N.J., December 1, 2014 – Zoetis is pleased to announce that the American Animal Hospital Association (AAHA) has selected the company’s Pet Wellness Report® (PWR) as AAHA’s exclusive Preferred Business Provider for Health Risk Assessments in veterinary medicine. AAHA accredited hospitals are traditionally on the forefront of advancing new approaches to medical care for companion animals. The endorsement lends credibility to this innovative communication tool, which furthermore...
  • April 8, 2014
    Zoetis joined a new initiative working to advance the standards of small animal veterinary care across Africa. The African Small Companion Animal Network (AFSCAN) aims to facilitate the creation of a sustainable network of companion animal veterinarians, associations and specialist groups in sub-Saharan Africa. This network will facilitate the formation of new Small Animal Veterinary Associations (SAVAs) across the continent. Read the full press release here.more...
  • February 26, 2014
    FLORHAM PARK, N.J. - February 26, 2014 - The Winn Feline Foundation, in a unique funding opportunity sponsored by Zoetis Inc., announced today a call for proposals to address the assessment of pain, osteoarthritis, joint health and kidney disease in cats. A total of $100,000 is available to fund proposals of sufficient scientific merit, relevance and potential to impact feline health. Consideration will be given to proposals investigating novel biomarkers for assessing acute or chronicmore...
  • January 29, 2014
    PARIS, FRANCE, January 29, 2014 – Zoetis Inc. announced today the launch of Apoquel® (oclacitinib maleate), a novel therapy indicated for the treatment of pruritus (itching) associated with canine allergic dermatitis and the clinical manifestations of atopic dermatitis. Veterinarians across Europe now have a first-in-class treatment choice that targets the itch of allergic skin conditions in dogs.Apoquel is the first Janus Kinase (JAK) inhibitor approved for veterinary use. It provides rapidmore...
  • January 20, 2014
    FLORHAM PARK, N.J. – Jan. 20, 2014 – Zoetis Inc. today announced that APOQUEL® (oclacitinib tablet) is now available to veterinarians in the United States for the control of pruritus, or itching, associated with allergic dermatitis and the control of atopic dermatitis in dogs at least 12 months of age. With APOQUEL, veterinarians now have a first-in-class treatment choice that targets the itch of allergic skin conditions at its source. Canine itching is among the most frequent complaints ofmore...
  • October 22, 2013
    From the cows that provide the milk for a bowl of cereal to the deer nibbling on a shrub in the park, from sea lions working with their trainers at the zoo to puppies chasing balls in the yard, the connections humans have with animals are vast. This special relationship is explored in a new mobile exhibit from the Smithsonian.“Animal Connections: Our Journey Together,” a custom-built exhibition housed on an 18-wheel truck that expands into 1,000 square feet of space, will be on view on themore...
  • September 19, 2013
    FLORHAM PARK, N.J. – September 19, 2013 – Zoetis, Inc. (NYSE: ZTS), formerly the animal health business unit of Pfizer Inc., today announced that following a positive opinion from the Committee for Medicinal Products for Veterinary Use (CVMP), the European Commission has approved APOQUEL® (oclacitinib tablet) in the European Union for the treatment of pruritus associated with allergic dermatitis and the treatment of clinical manifestations of atopic dermatitis in dogs at least 12 months of agemore...